Regulus Therapeutics Inc - RGLS - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Regulus Therapeutics Inc - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
RGLS	Nasdaq	8731	http://www.regulusrx.com	9.99 +0.09
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Regulus Therapeutics Inc REGULUS THERAPEUTICS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - Jun 12th, 2013 7:07 am Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors - Jun 11th, 2013 7:25 am Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors - Jun 11th, 2013 6:00 am REGULUS THERAPEUTICS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement - Jun 10th, 2013 7:12 am 3 Stocks to Get on Your Watchlist - Jun 5th, 2013 11:37 am IPOVIEW-Quiet U.S. biotech sector picks up steam in 2013 - May 22nd, 2013 7:53 am Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference - May 21st, 2013 2:05 pm REGULUS THERAPEUTICS INC. Financials - May 21st, 2013 11:04 am REGULUS THERAPEUTICS INC. Financials - May 21st, 2013 11:04 am REGULUS THERAPEUTICS INC. Files SEC form 10-Q, Quarterly Report - May 14th, 2013 9:06 pm Regulus Therapeutics CEO Discusses Q1 2013 Results - Earnings Call Transcript - May 14th, 2013 6:17 pm Regulus Provides Update on 'Road to the Clinic' Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights - May 14th, 2013 2:05 pm Q1 2013 Regulus Therapeutics Earnings Release - After Market Close - May 14th, 2013 5:07 am Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call - May 7th, 2013 2:05 pm Regulus Therapeutics: Strong Balance Sheet As It Moves Into Clinical Development - May 6th, 2013 12:40 pm 3 Investment Ideas for Biotech Investors - May 1st, 2013 4:11 pm Regulus to Present at 12th Annual Needham Healthcare Conference - Apr 24th, 2013 2:05 pm 3 Stocks Near 52-Week Highs Worth Selling - Apr 18th, 2013 10:03 am Zosano Pharma, Inc. Expands Board of Directors with Addition of Kleanthis G. Xanthopoulos, Ph.D. - Apr 15th, 2013 9:00 am Why Regulus Therapeutics Is Poised to Keep Plunging - Apr 5th, 2013 10:45 am View All Current Headlines >>